(Q37911044)

25 August 2017

1 reference

title

Oxidative stress in phenylketonuric patients (English)

1 reference

25 August 2017

1 reference

C R Vargas

1

1 reference

25 August 2017

M Wajner

series ordinal

2

1 reference

25 August 2017

A Sitta

series ordinal

3

1 reference

25 August 2017

publication date

22 July 2011

1 reference

Molecular Genetics and Metabolism

25 August 2017

published in

1 reference

25 August 2017

volume

104 Suppl

1 reference

25 August 2017

page(s)

S97-9

1 reference

Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

An evaluation of the possible neurotoxicity of metabolites of phenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Antioxidant status in hyperphenylalaninemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

A longitudinal study of antioxidant status in phenylketonuric patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Lipophilic antioxidants in patients with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Cognitive functions and the antioxidant system in phenylketonuric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

L-carnitine blood levels and oxidative stress in treated phenylketonuric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Investigation of oxidative stress parameters in treated phenylketonuric patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Oxidative stress in patients with phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Decreased serum ubiquinone-10 concentrations in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Antioxidant and antiradical activities of L-carnitine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Serum carnitine level in phenylketonuric children under dietary control in Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

Evidence that l-Carnitine and Selenium Supplementation Reduces Oxidative Stress in Phenylketonuric Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.010

10.1016/J.YMGME.2011.07.010

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference